Mindfulness-Based Relapse Prevention with Individuals Receiving Medication-Assisted Outpatient Treatment for Opioid Use Disorder

Testing Mindfulness-Based Relapse Prevention with Medications for Opioid Use Disorder Among Adults in Outpatient Therapy: a Quasi-experimental Study

“…This study aimed to explore the effectiveness of MBRP with individuals receiving MOUD in a naturalistic, open-ended outpatient group treatment setting. Based on the preliminary work reported by Zullig et al ( 2018 ), we made several modifications to the intervention, which included utilizing a quasi-experimental study design, increasing the sample size, and extending the follow-up period length to 12-weeks post intervention. In addition, we also increased the number of MBRP sessions from 8 to 12 held every other week over the 24-week intervention period to explore whether MBRP could be delivered in open-ended manner consistent with traditional outpatient treatment.…”

“…Second, session format was expanded from an 8-week close-ended group in the pilot study (see Zullig et al, 2018 ) to a 12-week open-ended group (meeting once every 2 weeks for 24 weeks) for 12 total hours of programming. In the MBRP model, there are eight primary areas of focus, but instead of having each individual session focus on one topic, we integrated multiple topics into each session so that individuals could come and go into the group without missing an area of focus.…”

“…In a preliminary study, Zullig et al ( 2018 ) reported that among completers of the 8-week MBRP/MOUD outpatient intervention, significant reductions were observed in reported depression and significant increases were observed in reported mindfulness when compared to those in treatment as usual (TAU) MOUD. However, this preliminary research was limited by its single group study design where participants served as their own controls (i.e., each participant participated in 8 weeks of TAU/MOUD before the 8-week MBRP/MOUD intervention phase began), follow-up measurement length, and small sample size.…”

Effectiveness of Mindfulness-Based Relapse Prevention in Individuals with Substance Use Disorders: A Systematic Review

“…We decided to include studies since 2016, as some studies published this year may not have been considered in the previous review. Regarding the country of origin, seven studies (53.8.5%) were carried out in the United States [19,20,[26][27][28][29][30], four (30.7%) in Iran [31][32][33][34], and two (15.3%) in France [22,35]. The sample sizes ranged from 6 to 191.…”

“…The sample sizes ranged from 6 to 191. The type of population used was different among the studies: four (30.7%) used only individuals with alcohol use disorder [19,20,22,29], three (23.0%) included individuals with substance use disorder related to methadone [31][32][33], and two (15.3%) used individuals with a stimulant and opioid use disorder, respectively [26,30]. On the other hand, three studies (23.0%) had heterogeneous samples, including individuals with various substance use disorders [28,34,35].…”